Read more:

Friday, March 20, 2015

Global CKD Drugs Market Will Set At CAGR of 1.21% From 2014 To 2019: just Published

Chronic Kidney Disease (CKD) Drugs Market 2015-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -

To Read the Complete Report with Toc Visit:

According to WHO, CKD is not only common, treatable, and harmful but also a major contributing factor to the incidence and outcomes of at least three of the diseases that are targeted by WHO (hypertension, diabetes, and CVD). CKD is mainly defined as a reduced GFR, increased urinary albumin excretion, or both, and is growing public health issue. CKD is classified into five stages (stages 1-5) according to renal function and the level of urinary protein excretion as measured by eGFR which is derived from race, gender, age, and serum creatinine concentration.
Global CKD Drugs market to grow at a CAGR of 1.21 percent over the period 2014-2019.

Covered in this Report

The Global CKD Drugs Market can be divided into two segments: Route of Administration which includes oral, SC, and IV and Mechanism of Action which includes ARBs, ACEIs, ESAs, PH Binders, and Vasodilators. This report covers the present scenario and the growth prospects of the Global CKD Drugs market for the period 2014–2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of CKD that are available in the market.

Global CKD Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA and APAC regions; it also covers the Global CKD Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Click Here To Download Detail Report:

Key Regions


Key Vendors

Actavis PLC
Amgen Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd

Other Prominent Vendors

Abbott Laboratories
Akebia Therapeutics
AMAG Pharmaceuticals
Cara Therapeutics
Keryx Biopharmaceuticals
Reata Pharmaceuticals
OPKO Health
Raptor Pharmaceuticals
Regulus Therapeutics
Rockwell Medical
Shield Therapeutics
Takeda Pharmaceuticals
Vifor Pharma Ltd
Xenetic Biosciences
ZS Pharma

Market Driver

Increase in Associated Disorders with CKD
For a full, detailed list, view our report.

Market Challenge

Genericization of Major Brands
For a full, detailed list, view our report.

Market Trend

Approval of New Pipeline Drugs
For a full, detailed list, view our report.

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse Our Press Releases by Prnewswire:

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. 

To View The Top Related News:

Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948

No comments:

Post a Comment